U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07017907) titled 'Evaluating an AI Tool for Detecting Thyrotoxic States' on June 04.
Brief Summary: This observational study aims to evaluate the performance of a software-based medical device, Glandy HYPER, in detecting the thyrotoxic state in patients with hyperthyroidism. The device utilizes heart rate data collected from commercially available wearable devices and compares it with thyroid function test results. The study will enroll patients diagnosed with Graves' disease, monitoring their heart rate during sleep and correlating these measurements with free T4 levels obtained through serial blood testing. No investigational device output will be ...